Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domain-Reference-Cited by-同舟云学术

Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domain

Published:2021-10 Issue:2 Volume:37 Page:109822
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Wheatley Adam K.^ORCID,Pymm Phillip,Esterbauer Robyn^ORCID,Dietrich Melanie H.^ORCID,Lee Wen Shi^ORCID,Drew Damien,Kelly Hannah G.,Chan Li-Jin^ORCID,Mordant Francesca L.^ORCID,Black Katrina A.^ORCID,Adair Amy^ORCID,Tan Hyon-Xhi,Juno Jennifer A.^ORCID,Wragg Kathleen M.,Amarasena Thakshila,Lopez Ester^ORCID,Selva Kevin J.,Haycroft Ebene R.,Cooney James P.,Venugopal Hariprasad,Tan Li Lynn^ORCID,O Neill Matthew T.,Allison Cody C.^ORCID,Cromer Deborah,Davenport Miles P.,Bowen Richard A.,Chung Amy W.,Pellegrini Marc^ORCID,Liddament Mark T.^ORCID,Glukhova Alisa,Subbarao Kanta,Kent Stephen J.^ORCID,Tham Wai-Hong^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference78 articles.

1. A serological assay to detect SARS-CoV-2 seroconversion in humans;Amanat;Nat Med,2020

2. Extremely potent human monoclonal antibodies from COVID-19 convalescent patients;Andreano;Cell,2021

3. CD40/anti-CD40 antibody complexes which illustrate agonist and antagonist structural switches;Argiriadi;BMC Mol. Cell Biol.,2019

4. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies;Barnes;Nature,2020

5. Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies;Barnes;Cell,2020

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epitope mapping of SARS-CoV-2 RBDs by hydroxyl radical protein footprinting reveals the importance of including negative antibody controls;Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics;2024-07

2. Humoral Immunity across the SARS-CoV-2 Spike after Sputnik V (Gam-COVID-Vac) Vaccination;Antibodies;2024-05-11

3. SARS‐CoV‐2 infection triggers more potent antibody‐dependent cellular cytotoxicity (ADCC) responses than mRNA‐, vector‐, and inactivated virus‐based COVID‐19 vaccines;Journal of Medical Virology;2024-03

4. Exploring the Interplay of Mutations, Viral Stability, and Implications for Innovative Vaccination Strategies and Therapeutic Approaches Among Various SARS-CoV-2 Variants;2024-01-03

5. SARS-CoV-2 spike protein binding ligands and its application in COVID-19 therapeutics;Features, Transmission, Detection, and Case Studies in COVID-19;2024